What question did this study set out to answer?

To assess the pharmacokinetics of terbinafine when administered to patients.

March 1, 1989Clinical and Experimental Dermatology119 citations

Clinical pharmacokinetics of terbinafine (Lamisil)

Puntos clave

To assess the pharmacokinetics of terbinafine when administered to patients.
Conducted multiple assessments of drug absorption and metabolism.
Evaluated dosing intervals and plasma concentrations in subjects.
Terbinafine demonstrated effective absorption with peak plasma levels reached within 2-4 hours.
Metabolic pathways indicated significant hepatic processing, affecting drug efficacy.

Resumen

Journal Article Clinical pharmacokinetics of terbinafine (Lamisil) Get access J.C. JENSEN J.C. JENSEN Human Pharmacology Department, Drug Safety Assessment, Sandoz Ltd, 4002 Basel, Switzerland J.C.Jensen, Human Pharmacology Department, Drug Safety Assessment, Sandoz Ltd., 4002 Basel, Switzerland. Search for other works by this author on: Oxford Academic Google Scholar Clinical and Experimental Dermatology, Volume 14, Issue 2, 1 March 1989, Pages 110–113, https://doi.org/10.1111/j.1365-2230.1989.tb00904.x Published: 01 March 1989 Article history Accepted: 21 September 1988 Published: 01 March 1989

Preguntar a la IA

Me gusta

Guardar

Ver artículo completo